Here's Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today
Stocks are extending losses on Tuesday, mainly due to healthcare sector, which is down over 2%, and slipping crude prices.
Supernus Pharmaceuticals Inc. (SUPN)
Market is closed
News
- First
- << Previous
- 31 - 40
Should You Buy Supernus Pharmaceuticals Inc (SUPN)?
Looking for high-potential stocks? Just follow the big players within the hedge fund industry! This is not an ad, but let’s take a brief look at what statistics has to say about hedge funds’ stock...
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Philip Hempleman, Ardsley Partners Initiate Position in Supernus Pharmaceuticals Inc (SUPN)
Philip Hempleman has become a fan of Supernus Pharmaceuticals Inc (NASDAQ:SUPN).
Orchard Hill Reports a 10% Stake in Supernus Pharmaceuticals
Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained 3.5 million shares, a new...
Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren't Crazy About It, Insider Sentiment Unchanged
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
Big Movers News: Biodel Inc (BIOD)'s Big News, Supernus Pharmaceuticals Inc (SUPN)'s Spike
Biodel had its price target increased by JMP Securities from $6.00 to $9.00 in a research report sent to investors on Thursday morning, StockRatingsNetwork.com reports.
Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.
Hedge Funds Aren't Crazy About Hi-Tech Pharmacal Co. (HITK) Anymore
In the 21st century investor’s toolkit, there are tons of indicators shareholders can use to monitor stocks. A duo of the most underrated are hedge fund and insider trading interest.
Hedge Funds Are Betting On Supernus Pharmaceuticals Inc (SUPN)
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to watch stocks. A couple of the most innovative are hedge fund and insider trading activity.
- First
- << Previous
- 31 - 40
Billionaire Hedge Funds
